Regencell Bioscience Holdings Ltd is 3.5x more valuable than Definium Therapeutics, Inc. by market capitalization ($9.34 B vs $2.65 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RGC | DFTX |
|---|---|---|
| Market cap | $9.34 B | $2.65 B |
| US-listed rank | #983 | #1913 |
| Net income (latest FY) | -$3.58M | -$183.79M |
| SEC filings | 82 | 445 |
Regencell Bioscience Holdings Ltd is 3.5x more valuable than Definium Therapeutics, Inc. by market capitalization ($9.34 B vs $2.65 B).
Full pages: Regencell Bioscience Holdings Ltd and Definium Therapeutics, Inc., or browse the full rankings.